Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Aromando Andrew
Chief Business Officer at ONCOLYTICS BIOTECH. Filing since 11 Feb 2026.
CIK 0001976455
Company
Date
Role
Action
Shares
Amount
Of holding
ONCY
ONCOLYTICS BIOTECH INC
11 Feb 2026
Chief Business Officer
Bought
29,600
$25.42K
116%
1 decision on file.